RecensMedical Corrects Annual Report for Clerical Errors No Impact on Shareholder Value as Financial Figures Unchanged

RecensMedical submitted a correction to its annual report on July 9, 2026, addressing the omission of the treasury stock report and XBRL tagging errors.
This amendment involves only clerical format supplements and error corrections with no changes to financial statements, thus having no real financial impact on investors.
The donation of 117,300 shares by co-CEO Kim Geonho as treasury stock and subsequent sale to the employee stock ownership plan was already disclosed and remains unchanged.
The company did not pay dividends for fiscal year 2025 and recorded a net loss of KRW 19.1 billion, providing no shareholder returns.
[AI Summary]This corrective filing is an administrative supplement without altering any financial figures, creating no new investment risks or opportunities. The existing operational losses and negative equity persist, limiting short-term price catalysts.